Operating Lease, Right-of-Use Asset of Cogent Biosciences, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cogent Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Cogent Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $18,591,000, a 9.7% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cogent Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $18,591,000 -$1,989,000 -9.7% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $19,097,000 -$1,960,000 -9.3% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $19,599,000 -$1,932,000 -9% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $20,097,000 -$1,901,000 -8.6% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 $20,580,000 -$1,614,000 -7.3% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $21,057,000 -$1,411,000 -6.3% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $21,531,000 -$1,591,000 -6.9% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $21,998,000 -$1,318,000 -5.7% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $22,194,000 -$1,638,000 -6.9% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $22,468,000 -$4,423,000 -16% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $23,122,000 +$19,925,000 +623% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $23,316,000 +$20,545,000 +741% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $23,832,000 +$20,583,000 +634% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $26,891,000 +$23,176,000 +624% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $3,197,000 -$972,000 -23% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $2,771,000 -$1,844,000 -40% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 $3,249,000 -$1,797,000 -36% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $3,715,000 -$852,000 -19% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $4,169,000 -$760,000 -15% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 $4,615,000 -$670,000 -13% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 $5,046,000 -$588,000 -10% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $4,567,000 -$1,410,000 -24% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 $4,929,000 -$1,387,000 -22% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $5,285,000 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 $5,634,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $5,977,000 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 $6,316,000 31 Mar 2019 10-Q 13 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.